Details of Disease | DrugMAP

General Information of Disease (ID: DIS4PG4J)

Disease Name	Blepharoconjunctivitis
Definition	Inflammation of both the eyelids and the conjunctiva.
Disease Hierarchy	DISWD40R: Disease DISGOZ4P: Conjunctivitis DISXQGF5: Blepharitis DIS4PG4J: Blepharoconjunctivitis
Disease Identifiers	MONDO ID MONDO_0002307 UMLS CUI C0005743 MedGen ID 2669 SNOMED CT ID 68659002

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 13 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Bacitracin	DM5OHYE	Approved	Small molecular drug	[1]
Cortisone Acetate	DMG8K57	Approved	Small molecular drug	[2]
Dexamethasone	DMMWZET	Approved	Small molecular drug	[3]
Framycetin	DMF8DNE	Approved	Small molecular drug	[4]
Fusidic Acid	DMWVCF3	Approved	Small molecular drug	[5]
Gentamicin	DMKINJO	Approved	Small molecular drug	[6]
Gramicidin D	DMPT74U	Approved	Small molecular drug	[4]
Hydrocortisone	DMGEMB7	Approved	Small molecular drug	[7]
Polymyxin B Sulfate	DMN0LP8	Approved	Small molecular drug	[8]
Prednisolone	DMQ8FR2	Approved	Small molecular drug	[9]
Sulfacetamide	DMZ6VEY	Approved	Small molecular drug	[10]
Tobramycin	DMUI0CH	Approved	Small molecular drug	[11]
Trimethoprim	DMM7CHK	Approved	Small molecular drug	[12]
------------------------------------------------------------------------------------


⏷ Show the Full List of 13 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Bacitracin FDA Label
2	Cortisone acetate FDA Label
3	Dexamethasone FDA Label
4	A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
5	Fusidic acid viscous eyedrops--an evaluation of pharmacodynamics, pharmacokinetics and clinical use for UK optometrists. Ophthalmic Physiol Opt. 2006 Jul;26(4):343-61.
6	Gentamicin FDA Label
7	Hydrocortisone FDA Label
8	Polymyxin B Sulfate FDA Label
9	Prednisolone FDA Label
10	Sulfacetamide FDA Label
11	Tobramycin FDA Label
12	Trimethoprim FDA Label